New Zealand shares rose to a new record, led by a recovery in Comvita after the manuka honey health products maker downplayed the impact the Myrtle Rust fungal disease would have on the wider industry, while Tower jumped on news its board was backing an Australian takeover bid.
The S&P/NZX 50 Index climbed 30.85 points, or 0.4 per cent, to 7,626.35, having reached an intraday high of 7,637.05. Within the index, 27 stocks rose, 15 fell and eight were unchanged. Turnover was $130 million.
Comvita led the benchmark index higher, rising 6.7 per cent to a month-high close of $5.87 after the Te Puke-based company said Myrtle Rust posed a low risk to the manuka honey industry based on Australia's experience.
"Investors were pretty cautious about that and that news certainly boosted that share price," said Grant Williamson, a director at Hamilton Hindin Greene in Christchurch. The Myrtle Rust outbreak was the latest in a string of bad news for Comvita's share price, pushing it near two-year lows, and Williamson said it was "a nice recovery today seeing the bargain hunters come in."
Williamson said the America's Cup victory by Emirates Team New Zealand didn't give the market the same boost as in the past, although local success on the international scene tended to help investor sentiment.